These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 10327772)

  • 41. [Use of statins in primary prevention: from the theoretical presuppositions to complex scenarios of the real world].
    Poli A; Menotti A
    G Ital Cardiol; 1999 Oct; 29(10):1123-30. PubMed ID: 10546121
    [No Abstract]   [Full Text] [Related]  

  • 42. [Are there differences in various statins?].
    Otto C; Schwandt P
    Internist (Berl); 1998 Sep; 39(9):987-93. PubMed ID: 9788127
    [No Abstract]   [Full Text] [Related]  

  • 43. Cholesterol reduction and coronary prevention.
    Prabhakaran D
    Natl Med J India; 1997; 10(1):24-5. PubMed ID: 9069704
    [No Abstract]   [Full Text] [Related]  

  • 44. Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study.
    Hague W; Forder P; Simes J; Hunt D; Tonkin A;
    Am Heart J; 2003 Apr; 145(4):643-51. PubMed ID: 12679760
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cholesterol: blood levels or total risk as a guide to preventive treatment?].
    Mathes P
    Z Kardiol; 2004; 93 Suppl 2():II16-20. PubMed ID: 15021991
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PRINCE's prospects: statins, inflammation, and coronary risk.
    Azar RR; Waters DD
    Am Heart J; 2001 Jun; 141(6):881-3. PubMed ID: 11376298
    [No Abstract]   [Full Text] [Related]  

  • 47. Review of recent clinical trials of lipid lowering in coronary artery disease.
    Smith SC
    Am J Cardiol; 1997 Oct; 80(8B):10H-13H. PubMed ID: 9372993
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pravastatin and coronary heart disease.
    Assmann G; Schulte H; Cullen P
    Circulation; 1998 Dec 22-29; 98(25):2933-4. PubMed ID: 9860800
    [No Abstract]   [Full Text] [Related]  

  • 49. Prevention of coronary heart disease with pravastatin.
    Samani NJ; de Bono DP
    N Engl J Med; 1996 May; 334(20):1333-4; author reply 1334-5. PubMed ID: 8609957
    [No Abstract]   [Full Text] [Related]  

  • 50. Improved survival with statin therapy.
    Clem JR
    S D J Med; 1996 Aug; 49(8):273-4. PubMed ID: 8803474
    [No Abstract]   [Full Text] [Related]  

  • 51. Clinical prevention of coronary heart disease through cholesterol-lowering therapy.
    Grundy SM
    Curr Ther Endocrinol Metab; 1997; 6():520-6. PubMed ID: 9174799
    [No Abstract]   [Full Text] [Related]  

  • 52. Statins and coronary heart disease.
    Oliver MF
    Lancet; 1996 Jul; 348(9019):57. PubMed ID: 8691943
    [No Abstract]   [Full Text] [Related]  

  • 53. Prevention of coronary heart disease with pravastatin.
    Davis DR
    N Engl J Med; 1996 May; 334(20):1334; author reply 1335. PubMed ID: 8609958
    [No Abstract]   [Full Text] [Related]  

  • 54. Therapy and clinical trials.
    Sussekov AV
    Curr Opin Lipidol; 1997 Oct; 8(5):U73-5. PubMed ID: 9335964
    [No Abstract]   [Full Text] [Related]  

  • 55. Lowering cholesterol in patients with coronary heart disease: are we ready yet?
    Barrett-Connor E
    Circulation; 1997 Dec; 96(12):4124-5. PubMed ID: 9416875
    [No Abstract]   [Full Text] [Related]  

  • 56. The effects of changing statins on cholesterol levels.
    Mann S; Clare G
    N Z Med J; 1999 Jul; 112(1091):260. PubMed ID: 10448988
    [No Abstract]   [Full Text] [Related]  

  • 57. Prevention of coronary heart disease with pravastatin.
    Rogers S
    N Engl J Med; 1996 May; 334(20):1333; author reply 1334-5. PubMed ID: 8609956
    [No Abstract]   [Full Text] [Related]  

  • 58. Economic benefit analysis of primary prevention with pravastatin. Modelling economic benefits after such long term treatment is inappropriate.
    Pharoah P
    BMJ; 1998 Apr; 316(7139):1241-2. PubMed ID: 9553009
    [No Abstract]   [Full Text] [Related]  

  • 59. Cholesterol-lowering drugs for primary prevention? The WOSCOP Study.
    Muntoni S
    Pharmacol Res; 1997 Mar; 35(3):169-70. PubMed ID: 9229402
    [No Abstract]   [Full Text] [Related]  

  • 60. Hormone therapy versus statins for cholesterol reduction.
    Harv Heart Lett; 1998 Apr; 8(8):6-7. PubMed ID: 9549437
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.